Suppr超能文献

用短的HIV Gag p24样肽对HIV感染患者进行皮内接种可诱导持续超过七年的CD4 +和CD8 + T细胞应答。

Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.

作者信息

Lind Andreas, Sommerfelt Maja, Holmberg Jens Olof, Baksaas Ingebjørg, Sørensen Birger, Kvale Dag

机构信息

Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.

出版信息

Scand J Infect Dis. 2012 Aug;44(8):566-72. doi: 10.3109/00365548.2011.653581. Epub 2012 Feb 19.

Abstract

BACKGROUND

Vacc-4x contains 4 HIV p24-like short peptides. In a previous phase II trial this immunized 90% of 38 patients on antiretroviral treatment (ART) after intradermal delivery in conjunction with local granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjuvant. In this study, 22 responders were retested for cellular memory at a median 7.3 y after their last immunization. All had resumed effective ART after an interspersed ART-free median interval of 2.2 y.

METHODS

Vacc-4x as 15-mer overlapping by 2 amino acid panels and Vacc-4x consensus peptide sequences (4xCP) were used as antigens. Proliferation was determined as percentages of CFSE(dim)HLA-DR(+) 7AAD(-) CD3+ T cells of the CD4+ and CD8+ subsets after 6 days of culture. Frequencies of specific T cells in 6-h cultures were determined by interferon-γ (IFN)(+) CD4+ and IFN(+) CD8+, as well as degranulating bifunctional CD107a + IFN(+) CD8 + subsets.

RESULTS

Proliferative CD4+ and CD8+ responses to Vacc-4x as well as 4xCP were still present in 95% and 68%, respectively. Proliferation correlated with the Vacc-4x delayed-type hypersensitivity test (DTH) obtained after completed immunizations (CD4 + r = 0.63 (p = 0.002) and CD8 + r = 0.47 (p = 0.03)), suggesting that they represent T cell memory recall responses. The proliferative CD8+ and possibly CD4 + subset responses to 4xCP peptides correlated with Vacc-4x (r = 0.46 (p = 0.03) and r = 0.38 (p = 0.08), respectively). Forty-one percent still had Vacc-4x-specific IFN + CD4 + T cells, which correlated to corresponding frequencies of 4xCP peptides (r = 0.50, p = 0.02). CD107a(+) IFN(+) CD8 + T cell responses against Vacc-4x were found in 55%.

CONCLUSIONS

Evidence of long-lasting T cell memory recall responses to a peptide-based immunotherapeutic candidate for HIV-infected patients should enhance the focus on peptide-based intradermal vaccine delivery.

摘要

背景

Vacc-4x包含4种HIV p24样短肽。在先前的一项II期试验中,38例接受抗逆转录病毒治疗(ART)的患者在皮内注射并联合局部粒细胞-巨噬细胞集落刺激因子(GM-CSF)作为佐剂后,90%的患者产生了免疫反应。在本研究中,对22名有反应者在最后一次免疫后中位7.3年进行了细胞记忆重新检测。所有人在中位2.2年的无ART间隔后都恢复了有效的ART治疗。

方法

使用由2个氨基酸重叠的15聚体Vacc-4x和Vacc-4x共有肽序列(4xCP)作为抗原。培养6天后,通过CFSE(dim)HLA-DR(+)7AAD(-)CD3+ T细胞在CD4+和CD8+亚群中的百分比来测定增殖情况。通过干扰素-γ(IFN)(+)CD4+和IFN(+)CD8+以及脱颗粒双功能CD107a + IFN(+)CD8 +亚群来测定6小时培养物中特异性T细胞的频率。

结果

对Vacc-4x以及4xCP的增殖性CD4+和CD8+反应分别仍存在于95%和68%的患者中。增殖与完成免疫后获得的Vacc-4x迟发型超敏反应试验(DTH)相关(CD4 + r = 0.63(p = 0.002),CD8 + r = 0.47(p = 0.03)),表明它们代表T细胞记忆回忆反应。对4xCP肽的增殖性CD8+以及可能的CD4 +亚群反应与Vacc-4x相关(分别为r = 0.46(p = 0.03)和r = 0.38(p = 0.08))。41%的患者仍有Vacc-4x特异性IFN + CD4 + T细胞,这与4xCP肽的相应频率相关(r = 0.50,p = 0.02)。55%的患者发现了针对Vacc-4x的CD107a(+)IFN(+)CD8 + T细胞反应。

结论

对于HIV感染患者,基于肽的免疫治疗候选物具有持久T细胞记忆回忆反应的证据应增强对基于肽的皮内疫苗递送的关注。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验